| AFSTYLA 1000 IU powder and solvent for solution for injection EU/1/16/1158/003 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 1500 IU powder and solvent for solution for injection EU/1/16/1158/004 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 2000 IU powder and solvent for solution for injection EU/1/16/1158/005 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 250 IU powder and solvent for solution for injection EU/1/16/1158/001 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 2500 IU powder and solvent for solution for injection EU/1/16/1158/006 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 3000 IU powder and solvent for solution for injection EU/1/16/1158/007 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| AFSTYLA 500 IU powder and solvent for solution for injection EU/1/16/1158/002 |
Lonoctocog alfa |
CSL Behring GmbH |
— |
| Alburex 20, 200 g/l, solution for infusion PA0800/008/002 |
Human albumin |
CSL Behring GmbH |
Not marketed |
| Alburex 5, 50 g/l, solution for infusion PA0800/008/001 |
Human albumin |
CSL Behring GmbH |
Not marketed |
| ANDEMBRY 200 mg solution for injection in pre-filled pen EU/1/24/1885/003-004 |
Garadacimab |
CSL Behring GmbH |
— |
| ANDEMBRY 200 mg solution for injection in pre-filled syringe EU/1/24/1885/001-002 |
Garadacimab |
CSL Behring GmbH |
— |
| Berinert 1500 IU Powder and solvent for solution for injection PA0800/013/002 |
C1 Esterase Inhibitor (Human) |
CSL Behring GmbH |
Not marketed |
| Berinert 2000 IU Powder and solvent for solution for injection PA0800/013/003 |
C1 Esterase Inhibitor (Human) |
CSL Behring GmbH |
Not marketed |
| Berinert 3000 IU Powder and solvent for solution for injection PA0800/013/004 |
C1 Esterase Inhibitor (Human) |
CSL Behring GmbH |
Not marketed |
| Berinert 500 IU Powder and solvent for solution for injection/infusion. PA0800/013/001 |
C1 Esterase Inhibitor (Human) |
CSL Behring GmbH |
Marketed |
| Beriplex P/N 1000 IU, powder and solvent for solution for injection PA0800/010/003 |
Factor ii activity, Factor vii activity, Factor x activity, Factor ix activity, Protein c activity |
CSL Behring GmbH |
Not marketed |
| Beriplex P/N 250 IU, powder and solvent for solution for injection PA0800/010/001 |
Factor ii activity, Factor vii activity, Factor x activity, Factor ix activity, Protein c activity |
CSL Behring GmbH |
Not marketed |
| Beriplex P/N 500 IU, powder and solvent for solution for injection PA0800/010/002 |
Factor ii activity, Factor vii activity, Factor x activity, Factor ix activity, Protein c activity |
CSL Behring GmbH |
Marketed |
| Hemgenix 1 x 10^13 genome copies/mL concentrate for solution for infusion EU/1/22/1715/001 |
Etranacogene dezaparvovec |
CSL Behring GmbH |
— |
| Hizentra 200 mg/ml solution for subcutaneous injection EU/1/11/687/001-12 |
Human normal immunoglobulin |
CSL Behring GmbH |
— |
| Human Albumin CSL Behring, 200 g/l, solution for infusion PA0800/012/001 |
Human albumin solution |
CSL Behring GmbH |
Not marketed |
| IDELVION 1000 IU powder and solvent for solution for injection EU/1/16/1095/003 |
Rix-fp |
CSL Behring GmbH |
— |
| IDELVION 2000 IU powder and solvent for solution for injection EU/1/16/1095/004 |
Rix-fp |
CSL Behring GmbH |
— |
| IDELVION 250 IU powder and solvent for solution for injection EU/1/16/1095/001 |
Rix-fp |
CSL Behring GmbH |
— |
| IDELVION 3500 IU powder and solvent for solution for injection EU/1/16/1095/009 |
Albutrepenonacog Alfa |
CSL Behring GmbH |
— |
| IDELVION 500 IU powder and solvent for solution for injection EU/1/16/1095/002 |
Rix-fp |
CSL Behring GmbH |
— |
| Privigen 100 mg/ml solution for infusion EU/1/08/446/1-3 |
Human normal immunoglobulin |
CSL Behring GmbH |
— |
| Respreeza 1,000 mg powder and solvent for solution for infusion. EU/1/15/1006/001 |
Human alpha1-proteinase inhibitor |
CSL Behring GmbH |
— |
| Rhophylac 300 micrograms/2 ml, solution for injection in pre-filled syringe PA0800/006/002 |
Human anti-D immunoglobulin |
CSL Behring GmbH |
Marketed |
| Riastap 1 g Powder for Solution for Injection/Infusion PA0800/007/001 |
Human fibrinogen |
CSL Behring GmbH |
Not marketed |
| Tetagam P, prefilled syringeSolution for injection for intramuscular use PA0800/009/002 |
Human plasma protein |
CSL Behring GmbH |
Marketed |
| Voncento 1000 IU/2400 IU Powder and solvent for solution for injection/infusion EU/1/13/857/004 |
Von willebrand factor, Human coagulation factor viii |
CSL Behring GmbH |
— |
| Voncento 250 IU/600 IU Powder and solvent for solution for injection/infusion EU/1/13/857/001 |
Human coagulation factor viii, Von willebrand factor |
CSL Behring GmbH |
— |
| Voncento 500 IU/1200 IU Powder and solvent for solution for injection/infusion EU/1/13/857/002 |
Von willebrand factor, Human coagulation factor viii |
CSL Behring GmbH |
— |
| Voncento 500 IU/1200 IU Powder and solvent for solution for injection/infusion EU/1/13/857/003 |
Human coagulation factor viii, Von willebrand factor |
CSL Behring GmbH |
— |